VASTNED 27.600 € (0,00 %) RETAIL ESTATES 61.700 € (0,00 %) WDP 19.340 € (+0,57 %) ONWARD MEDICAL 2.155 € (+0,47 %) ARGENX SE 786.600 € (+0,82 %) NYXOAH 0.852 € (-3,18 %) AB INBEV 73.980 € (-0,51 %) GIMV 47.250 € (-0,21 %) BREDERODE 97.400 € (+0,62 %) BEKAERT 40.950 € (+4,73 %) COLRUYT 36.020 € (-1,21 %) KINEPOLIS GROUP 51.100 € (+0,79 %) KBC ANCORA 94.600 € (+1,07 %) MONTEA 63.100 € (+0,80 %) UCB 213.000 € (-2,74 %) ACKERMANS V.HAAREN 261.000 € (-0,15 %) CENERGY 22.160 € (+1,74 %) BIOTALYS 1.664 € (-0,95 %) SYENSQO 78.850 € (+0,06 %) GBL 75.000 € (+3,45 %) IBA 16.120 € (-0,37 %) IMMOBEL 18.000 € (0,00 %) ASCENCIO 53.400 € (+1,91 %) ELIA GROUP 124.300 € (0,00 %) AGEAS 74.950 € (+1,22 %) EVS 18.280 € (-3,48 %) SOLVAY 23.580 € (-1,42 %) AZELIS GROUP 12.700 € (-2,46 %) CFE 10.950 € (+0,46 %) LOTUS BAKERIES 13 300.000 € (+0,91 %) BANQUP GROUP 0.978 € (-3,65 %) ENERGYVISION 17.480 € (-1,13 %) TUBIZE-FIN 180.400 € (-2,49 %) HYLORIS 3.900 € (-2,50 %) DECEUNINCK 2.400 € (+0,42 %) D'IETEREN GROUP 175.900 € (+0,51 %) ONTEX GROUP 1.718 € (+1,30 %) RECTICEL 11.060 € (-0,18 %) BARCO 6.390 € (+3,57 %) VAN DE VELDE 29.200 € (-0,68 %) AEDIFICA 63.200 € (+0,56 %) SOFINA 261.600 € (+1,00 %) SIPEF 110.000 € (-0,72 %) CMB.TECH 16.300 € (+5,30 %) CIE BOIS SAUVAGE 270.000 € (0,00 %) TINC 10.360 € (+0,39 %) EXMAR 11.450 € (+1,78 %) XIOR 23.750 € (-0,42 %) AGFA-GEVAERT 0.411 € (+0,49 %) JENSEN-GROUP 73.800 € (+0,82 %) CARE PROPERTY INV. 12.220 € (+0,33 %) PROXIMUS 5.520 € (-2,30 %) ECONOCOM GROUP 1.350 € (+1,89 %) DEME GROUP 167.600 € (+1,21 %) UMICORE 18.760 € (+0,97 %) TITAN S.A. 47.160 € (-0,08 %) SHURGARD 23.850 € (+0,63 %) BPOST 1.100 € (+0,92 %) HOME INVEST BE. 17.700 € (-1,34 %) KBC 116.100 € (+0,91 %)
LUMIBIRD 23.350 € (+2,19 %)
DRONE VOLT 0.254 € (+1,52 %)
AHOLD DEL 32.500 € (-1,16 %)
SANOFI 73.570 € (-0,01 %)
ENGIE 23.100 € (+1,18 %)
NANOBIOTIX 24.060 € (+13,49 %)
AIR LIQUIDE 173.600 € (+0,79 %)
BIOPHYTIS 0.034 € (+1,19 %)
VALLOUREC 18.535 € (+1,06 %)
ORANGE 14.100 € (-1,33 %)
Coca-ColaEuropacif 99.300 € (-1,29 %)
AEGON 7.548 € (+1,02 %)
CARVOLIX 5.920 € (+2,78 %)
WOLTERS KLUWER 85.100 € (+1,65 %)
AKZO NOBEL 60.960 € (+4,28 %)
ESSILORLUXOTTICA 173.800 € (+15,48 %)
AMUNDI 88.800 € (+1,14 %)
LVMH 388.600 € (+0,48 %)
IMCD 100.600 € (0,00 %)
ARAMIS GROUP 3.550 € (+1,28 %)
LEGRAND 131.300 € (+3,14 %)
UMG 16.205 € (+0,90 %)
ASM INTERNATIONAL 760.000 € (+2,73 %)
SPINEGUARD 0.085 € (0,00 %)
S.E.B. 57.900 € (-0,60 %)
SHELL PLC 46.840 € (+0,58 %)
BNP PARIBAS ACT.A 86.810 € (-0,16 %)
ASR NEDERLAND 74.600 € (+0,70 %)
AUBAY 49.700 € (+0,71 %)
RISING STONE 40.300 € (+0,50 %)
PROSUS 34.580 € (-3,06 %)
WERELDHAVE 17.240 € (+1,17 %)
CM.COM 6.390 € (-3,33 %)
WORLDLINE 11.462 € (+1,08 %)
WAVESTONE 31.600 € (+4,64 %)
BOLLORE 3.640 € (+0,05 %)
SCHNEIDER ELECTRIC 249.100 € (+1,96 %)
CARREFOUR 14.050 € (-13,80 %)
FDJ UNITED 21.010 € (-1,45 %)
AIRWELL 0.820 € (+6,49 %)
ABIVAX 84.350 € (+1,32 %)
ATOS GROUP 26.000 € (+13,84 %)
ALTEN 87.200 € (+3,44 %)
CORBION 24.200 € (-0,33 %)
LISI 61.600 € (+0,65 %)
ARCELORMITTAL SA 56.240 € (+0,21 %)
BIOMERIEUX 86.250 € (-1,09 %)
VIRBAC 345.500 € (+0,14 %)
VICAT 59.100 € (+0,34 %)
ADYEN 940.300 € (+1,71 %)
ROBERTET 769.000 € (-0,13 %)
CREDIT AGRICOLE 15.240 € (-0,03 %)
VALNEVA 2.472 € (-1,75 %)
GETLINK SE 19.380 € (+0,47 %)
ING GROEP N.V. 29.825 € (+1,48 %)
CAPGEMINI 125.050 € (+1,67 %)
EUTELSAT COMMUNIC. 1.899 € (+11,54 %)
INPOST 15.280 € (-2,05 %)
CSG 13.952 € (-5,58 %)
BOUYGUES 40.540 € (-0,27 %) News Réglementées
|
20/10/2026 09:01
Original-Research: ATOSS Software SE (von NuWays AG): BUYOriginal-Research: ATOSS Software SE - from NuWays AG Classification of NuWays AG to ATOSS Software SE
Steady quarter ahead, margin upside in reach ATOSS will release preliminary Q3 figures on Friday. We expect another strong quarter, which should make the margin guidance look conservative. In detail: We expect Q3 sales of € 53.3m (+12.9% yoy, eCons: € 53.3m), driven by continued strong momentum in Cloud & Subscription (eNuW: +25% yoy). Visibility remains good with Cloud ARR up 25% at H1 to € 114m and net retention of 111%. Larger enterprise migrations such as Rossmann and Berlin-Chemie should add to this, as contributions from migrations should further increase in Q3. Moreover, the broader rollout of the first ATC agent should support upselling. On the other hand, legacy licenses and maintenance should keep shrinking as planned, pushing the recurring share further up. On the bottom-line, we see an EBIT at € 18.4m (eCons: € 18.6m), implying a margin of 34.5%. We are deliberately conservative here, as on the one hand ATOSS keeps investing in sales capacity with sales headcount up 12% at H1 and on the other hand renewed geopolitical tensions and higher energy prices could lengthen decision cycles and keep pressure on new logo pricing. Nevertheless, cloud scaling and the internal AI rollout remain intact and management indicated in the Q2 CC, that holding or even exceeding the H1 level (35.1%) would not be a surprise. On FY26 guidance, management calls for sales of € 210-215m and an EBIT margin of ≥34%. For sales, our model indicates the mid-range with with € 213m (+12.4% yoy, eCons: € 213m). On EBIT however, we see ATOSS closer to the 35% (eNuW & eCons: 34.9%) despite our conservative H2 estimates, which do not reflect the typical H2 seasonality. An EBIT guidance upgrade with the Q3 release therefore remains a real possibility, in our view. Beyond FY26, management guides for FY27 sales of € 235-245m (eNuW & eCons: € 242m) and an EBIT margin of ≥35% (eNuW: 35.4%, eCons: 35.3%). The groundwork for this is already laid. With almost 74% of sales recurring and Cloud ARR growing 25% yoy, a large part of FY27 revenue is already visible. The installed base keeps expanding, which is visible in the strong net retention and driven by upselling and annual price increases. Large enterprise customers are moving to the cloud at higher ticket sizes while ATOSS’s moat in complex, highly regulated environments keeps switching costs high. Two new growth levers add to this: the ASES agents, launching at the end of Q4 and monetised through usage-based subscriptions, and the international business, which already accounts for 8% of sales (non-DACH +51% yoy at H1). On the margin side, cloud scaling and the internal AI rollout across development, sales and service should keep cost growth below revenue growth, making the outlook appear comfortable, in our view. Reiterate BUY with an unchanged € 134 PT based on DCF. You can download the research here: atoss-software-se-2026-10-20-previewreview-en-c2d5e For additional information visit our website: https://www.nuways-ag.com/research Contact for questions: NuWays AG - Equity Research Web: www.nuways-ag.com Email: research@nuways-ag.com LinkedIn: https://www.linkedin.com/company/nuwaysag Adresse: Mittelweg 16-17, 20148 Hamburg, Germany ++++++++++ Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte. Offenlegung möglicher Interessenkonflikte nach § 85 WpHG beim oben analysierten Unternehmen befindet sich in der vollständigen Analyse. ++++++++++ The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. 2418422 20.10.2026 CET/CEST Source : Webdisclosure.com |
||||||||||||||||||
© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière